Search results for "Sarcoma"

showing 10 items of 566 documents

Dual localization of oral Kaposi’s sarcoma in HIV-negative patient: a rare case report

2016

Not available

Settore MED/28 - Malattie Odontostomatologichedual localization kaposi's sarcoma hiv case report
researchProduct

Diagnosis and treatment of Ewing's Sarcoma of the tongue

2019

The Ewing's sarcoma Family of Tumors (EFT) includes classic Ewing's Sarcoma (ES) of bone, Extraskeletal Ewing's Sarcoma (EES) and malignant peripheral primitive Neuroectodermal Tumor (pNET) of bone and soft tissue. ES is an aggressive tumor with a high incidence of local recurrence and distant metastasis. The skeletal form is more common and typically occurs in the long bones of the extremities. The extra skeletal form occurs in the soft tissues of the lower extremities, paravertebral tissues, chest wall, retroperitoneum and rarely in the head and neck region in about 1- 4% of cases. Involvement of the head and neck is usually identified in the nasal or oral cavities, sinuses or soft tissue…

Settore MED/31 - OtorinolaringoiatriaEwing SarcomaSettore MED/32 - Audiologia
researchProduct

Ewing sarcoma family of tumors: Causes, diagnosis and treatment

2019

The Ewing's sarcoma Family of Tumors (EFT) includes classic Ewing's Sarcoma (ES) of bone, Extraskeletal Ewing's Sarcoma (EES) and malignant peripheral primitive Neuroectodermal Tumor (pNET) of bone and soft tissue. ES is an aggressive tumor with a high incidence of local recurrence and distant metastasis. The skeletal form is more common and typically occurs in the long bones of the extremities. The extra skeletal form occurs in the soft tissues of the lower extremities, paravertebral tissues, chest wall, retroperitoneum and rarely in the head and neck region in about 1-4% of cases. Involvement of the head and neck is usually identified in the nasal or oral cavities, sinuses or soft tissues…

Settore MED/31 - OtorinolaringoiatriaNeuroectodermal TumorEwing sarcomaSettore MED/32 - Audiologia
researchProduct

SOFT TISSUE SARCOMAS: Surgical Results from Italian Spft Tissue Sarcoma Group

1993

The Authors report the experience of the Italian Society of Paediatric Haematology and Oncology (AIEOP) in the treatment of Rhabdomyosarcoma, according to the Protocol ICS-RMS 88, is here reported.

Settore MED/38 - Pediatria Generale E SpecialisticaPaediatric solid tumours sarcoma Italian protocolSettore MED/20 - Chirurgia Pediatrica E Infantile
researchProduct

CHEMO-RESISTANT SOFT-TISSUE SARCOMAS (STS). Experience of the Italian Cooperative Study (ICS)

1993

The purpose of this study is to evaluete the Italian experience about localized Fivrosarcomas (FS) and Neurogenic Darcomas (NS)

Settore MED/38 - Pediatria Generale E SpecialisticaSettore MED/20 - Chirurgia Pediatrica E InfantilePaediatric tumours Soft Tissue Sarcomas
researchProduct

ROLE of SURGERY for NONMETASTATIC ABDOMINAL RRHABDOMYOSARCOMAS. A Report from the Italian and German Cooperative Groups Studies.

2003

In the current study, the Authors aim to evaluate clinical features and treatment results observed in patients from the German and Italian studies who had nonmetastatic abdominal rhabdomyosarcomas.

Settore MED/38 - Pediatria Generale E SpecialisticaSettore MED/20 - Chirurgia Pediatrica E InfantilePediatric Soft tissue sarcomas rhabdomyosarcomas surgery abdomen
researchProduct

Initial surgery for localized rhabdomyosarcoma: a report from the italian Soft Tissue Sarcoma Cooperative Group Studies.

2005

Objective. Analysis of the initial surgical approach in patients with localized rhabdomyosarcoma, enrolled in Italian Studies (1979-2003). Methods. Surgical records of 587 patients were evaluated. As primary surgery, the excision was recommended if microscopically complete, otherwise biopsy was preferable. Results. The initial biopsy, performed in almost 50% of patients in RMS-79 protocol, has been adopted more often in the protocol RMS-88 and 96. However, the “complete resection” rate has remained quite stable through the years, as well as the percentage of microscopic residue. The macroscopic residue disease has been more important in RMS-88 study than in RMS-96. Most GUnBP tumors and abo…

Settore MED/38 - Pediatria Generale E SpecialisticaSoft Tissue Sarcoma • Rhabdomyosarcoma • SurgerySettore MED/20 - Chirurgia Pediatrica E Infantile
researchProduct

Antibodies to human herpes virus type 8 (HHV8) in general population and in individuals at risk for sexually transmitted diseases in Western Sicily.

2000

Human herpes virus 8 (HHV8) appears to be the primary aetiologic agent of Kaposi sarcoma (KS). To study the distribution of HHV8, a seroepidemiological study was carried out in western Sicily, where a high incidence rate of classical KS is well documented.A total of 970 sera of healthy human immunodeficiency virus (HIV) negative individuals of general population (1-70 years old) and 742 sera of individuals in different risk groups for HIV infection were evaluated by means of an indirect immunofluorescence assay able to detect antibodies to lytic and latent HHV8 antigens.Crude seroprevalence to HHV8 antigens was 11.5% in the general population, and it increased significantly with age from 6%…

Sexually transmitted diseaseAdultMalemedicine.medical_specialtyAdolescentEpidemiologyPopulationSexually Transmitted DiseasesHIV InfectionsSerologyRisk FactorsSeroepidemiologic StudiesEpidemiologyMedicineSeroprevalenceHumansRisk factorHomosexuality MaleeducationChildSubstance Abuse IntravenousSarcoma KaposiSicilyAgededucation.field_of_studybusiness.industryTransmission (medicine)InfantGeneral MedicineHerpesviridae InfectionsMiddle AgedSex WorkHeterosexualityChild PreschoolImmunologyHerpesvirus 8 HumanFemalebusinessDemographyInternational journal of epidemiology
researchProduct

Silyl modification of biologically active compounds. 13. Synthesis, cytotoxicity and antibacterial action ofN-methyl-N-(2-triorganylsiloxyethyl)-1,2,…

2012

A series of N-methyl-N-(2-triorganylsiloxyethyl)-1,2,3,4-tetrahydro(iso)quinolinium iodides has been synthesized via dehydrocondensation reaction of N-(2-hydroxyethyl)-1,2,3,4-tetrahydroisoquinoline, N-(2-hydroxyethyl)-1,2,3,4-tetrahydroquinoline and 4,4-dimethyl-N-(2-hydroxyethyl)-4-sila-1,2,3,4-tetrahydroisoquinoline with trialkyl(aryl)hydrosilanes and subsequent alkylation, and characterized by 1H, 13C and 29Si NMR and mass spectroscopy. The biological activity data exhibited a marked enhancement of inhibitory activity against tumour cell lines and almost all the test bacterial/fungal strains in comparison with their 2-hydroxyethyl precursors. Cytotoxicity in the microgram range against …

SilylationStereochemistryArylBiological activityGeneral ChemistryAlkylationmedicine.diseaseInorganic Chemistrychemistry.chemical_compoundchemistryCell culturemedicineCholineCytotoxicityFibrosarcomaApplied Organometallic Chemistry
researchProduct

Matrix metalloproteinases 2 and 9, and extracellular matrix in Kaposi's sarcoma

2010

Matrix metalloproteinases (MMPs) are associated with Kaposi's sarcoma (KS) tumorigenesis and may contribute to the mechanism of KS invasive growth. To date, only a few MMPs have been studied in KS lesions, and exactly which MMPs are involved in KS development and progression remains unanswered. However, MMPs 2 and 9 have been associated with different phases of angiogenesis, but their role in the proteolytic modification of the extracellular matrix has not been investigated. The results of this study confirm that MMPs, specifically MMP-2 and MMP-9, can contribute to angiogenesis by disrupting the vessel basement membrane and other extracellular matrix barriers, and enabling endothelial cell…

Skin NeoplasmsAngiogenesisDermatologyMatrix metalloproteinasemedicine.disease_causeBasement MembraneExtracellular matrixCell Movementmatrix metalloproteinase-9Settore MED/35 - Malattie Cutanee E VenereemedicineHumansSarcoma KaposiKaposi's sarcomaBasement membraneNeovascularization Pathologicbusiness.industryGeneral Medicinemedicine.diseaseVirologyExtracellular Matrixmedicine.anatomical_structureMatrix Metalloproteinase 9Invasive growthsarcoma of KaposiCancer researchMatrix Metalloproteinase 2SarcomaCarcinogenesisbusinessmatrix metalloproteinase- 2Dermatologic Therapy
researchProduct